Squamous cell tumors in mice heterozygous for a null allele of Atp2a2, encoding the sarco(endo)plasmic reticulum

L H Liu1, G P Boivin, V Prasad

  • 1Departments of Molecular Genetics, Biochemistry and Microbiology and Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA.

Insights

Mutations in the ATP2A2 gene, encoding sarco(endo)plasmic reticulum Ca(2+)-ATPase isoform 2 (SERCA2), lead to Darier disease. Haploinsufficiency of SERCA2 in mice causes squamous cell tumors, indicating its role in cancer development.

Area of Science:

  • Oncology
  • Genetics
  • Cell Biology

Background:

  • Mutations in the ATP2A2 gene cause Darier disease, a skin disorder.
  • Reduced SERCA2 levels in mice impact cardiac function.
  • SERCA2 (sarco(endo)plasmic reticulum Ca(2+)-ATPase isoform 2) is crucial for calcium homeostasis.

Purpose of the Study:

  • To investigate the role of SERCA2 haploinsufficiency in cancer development.
  • To determine if reduced SERCA2 levels predispose to neoplasia.

Main Methods:

  • Analysis of aged heterozygous mutant (Atp2a2(+/-)) mice.
  • Tumor incidence assessment in mutant versus wild-type mice.
  • Western blot analysis to quantify SERCA2 protein levels in affected tissues.

Main Results:

  • Aged Atp2a2(+/-) mice developed squamous cell tumors in the forestomach, esophagus, oral mucosa, tongue, and skin (13/14 mice).
  • No tumors were observed in age- and sex-matched wild-type controls.
  • Reduced SERCA2 protein levels were confirmed in the skin and other affected tissues of heterozygous mice.

Conclusions:

  • SERCA2 haploinsufficiency predisposes murine keratinocytes to neoplasia, leading to squamous cell tumors.
  • Perturbation of calcium homeostasis/signaling by SERCA2 deficiency can initiate cancer.
  • This study provides the first direct evidence linking calcium signaling defects to cancer initiation.